These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8975256)

  • 1. [Against abuse of methodology in psychiatry].
    Bilikiewicz A
    Psychiatr Pol; 1996; 30(4):555-60. PubMed ID: 8975256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Geriatric psychiatry--a specialty within psychiatry].
    Engedal K; Bergem AL; Holm M; Bragason A; Moksnes KM
    Tidsskr Nor Laegeforen; 1997 Oct; 117(25):3684-7. PubMed ID: 9417666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Problems of psychogeriatrics].
    Bilikiewicz A
    Psychiatr Pol; 1995; 29(5):579-92. PubMed ID: 8577900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.
    DeBattista C; Belanoff J; Glass S; Khan A; Horne RL; Blasey C; Carpenter LL; Alva G
    Biol Psychiatry; 2006 Dec; 60(12):1343-9. PubMed ID: 16889757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.
    Rabey JM; Prokhorov T; Miniovitz A; Dobronevsky E; Klein C
    Mov Disord; 2007 Feb; 22(3):313-8. PubMed ID: 17034006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies in Polish psychiatric journals].
    Małyszczak K; Sieradzki A; Kiejna A
    Psychiatr Pol; 2003; 37(6):1083-90. PubMed ID: 14727379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of psychotic symptoms among elderly outpatients.
    Holroyd S; Laurie S
    Int J Geriatr Psychiatry; 1999 May; 14(5):379-84. PubMed ID: 10389042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics.
    Phillips LJ; Nelson B; Yuen HP; Francey SM; Simmons M; Stanford C; Ross M; Kelly D; Baker K; Conus P; Amminger P; Trumpler F; Yun Y; Lim M; McNab C; Yung AR; McGorry PD
    Aust N Z J Psychiatry; 2009 Sep; 43(9):818-29. PubMed ID: 19670055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotic symptoms in patients with bipolar mania.
    Canuso CM; Bossie CA; Zhu Y; Youssef E; Dunner DL
    J Affect Disord; 2008 Dec; 111(2-3):164-9. PubMed ID: 18378001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Devos D; Dujardin K; Poirot I; Moreau C; Cottencin O; Thomas P; Destée A; Bordet R; Defebvre L
    Mov Disord; 2008 Apr; 23(6):850-7. PubMed ID: 18311826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypotonic disorders of circulation regulation caused by therapy with psychotropic drugs. Treatment with 9alpha-fluorhydrocortisone].
    Volk W
    Med Welt; 1977 Nov; 28(45):1853-4. PubMed ID: 593126
    [No Abstract]   [Full Text] [Related]  

  • 20. [Placebo-controlled trials in schizophrenia].
    Melamed Y; Davidson M; Bleich A
    Harefuah; 2004 Mar; 143(3):236-40, 244. PubMed ID: 15065367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.